Related Experiment Video
Updated: Oct 1, 2026
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
Growth factor regulation of 17 beta-hydroxysteroid dehydrogenase activity in a human ovarian cell line: modulation by
Abstract:
We have examined the effects of IL-6 and bFGF on growth and reductive 17 beta-hydroxysteroid dehydrogenase (17-HSD) activity in a human ovarian cell line A2780 under defined culture conditions (standard RPMI (GM+PHR), phenol red-free RPMI (GM-PHR), or GM-PHR supplemented with 17 beta-estradiol). In media GM+PHR, neither factor influenced terminal cell density. However there was a 2-fold stimulation in 17-HSD activity (E1- > E2) in the presence of IL-6 and a 3-fold increase in the presence of bFGF. Cells cultured GM-PHR showed a 25-30% reduction in terminal cell density compared with cells cultured GM+PHR, and addition of factors resulted in a modest reduction (10-15%) in cell growth, with no detectable changes in 17-HSD. Addition of 17 beta-estradiol to GM-PHR cultures increased terminal cell density by up to 3-fold, with no effect on 17-HSD, and when combined with IL-6 or bFGF, a synergistic effect on growth was observed, but 17-HSD levels were unchanged. Our results suggest that cultured ovarian tumour cells respond to paracrine factors likely to be present in the ovary in vitro, and there is a possible interactive effect of estromedins with these factors.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
07:03A Modified Co-Culture System for Understanding Granulosa-Theca Cell Interactions in the Bovine Ovary
Published on: September 19, 2025
Related Concept Videos
02:07Oogenesis
01:24Regulation of Angiogenesis and Blood Supply
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:30Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...